Vera Therapeutics, Inc. - Class A (VERA) earnings
VERA earnings moved a median of -0.48% by the close. Quarterly and annual VERA reports and results, each read against the price at its own news timestamp. Back to the VERA overview →
20 measured VERA earnings events.
Where these VERA earnings landedvs 20 measured VERA earnings reactions
| Middle 50% of VERA earnings reactions | -2.47% to +3.30% |
|---|---|
| Median reaction (to close) | -0.48% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 VERA earnings events with a measured close landed between -2.47% and +3.30%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Vera Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.04% | -2.28% | |
| Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results | Press release | -4.04% | -2.28% | |
| Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast | Press release | -0.17% | +3.94% | |
| Form 10-Q Vera Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.22% | +1.00% | |
| Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results | Press release | +0.38% | -1.62% | |
| Form 10-K Vera Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.32% | +0.07% | |
| Form 10-Q Vera Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.58% | +7.41% | |
| Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results | Press release | -0.08% | -0.54% | |
| Form 10-Q Vera Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.21% | -4.18% | |
| Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results | Press release | +0.05% | +0.15% | |
| Form 10-Q Vera Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.84% | +4.00% | |
| Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results | Press release | -0.04% | -11.43% | |
| Form 10-K Vera Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.03% | -5.27% | |
| Form 10-Q Vera Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.50% | -0.41% | |
| Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results | Press release | +1.03% | +4.30% | |
| Form 10-Q Vera Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.32% | +3.21% | |
| Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results | Press release | -3.05% | -1.46% | |
| Form 10-Q Vera Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.85% | -4.22% | |
| Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results | Press release | -0.69% | -3.02% | |
| Form 10-K Vera Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.02% | +3.54% |
Keep exploring
More VERA: analyst actions → · SEC filings → · VERA overview →